Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
-
New drug combo tested to shrink pancreatic tumors before surgery
Disease control Not yet recruitingThis study aims to see if a new drug combination can help shrink pancreatic tumors before surgery. It will test an immunotherapy drug (adebrelimab) plus two standard chemotherapy drugs in about 30 patients. The goal is to see if this approach makes surgery more successful and imp…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Four-Pronged attack on tough liver cancer
Disease control Not yet recruitingThis study is testing a new combination of four different treatments for advanced liver cancer that cannot be removed by surgery. It will enroll 34 patients who have not yet received any treatment for their advanced cancer. Doctors will combine a targeted radiation procedure, a l…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Diabetes drug trial offers hope for rare gut disorder patients
Disease control Not yet recruitingThis study is testing whether a GLP-1 medication (semaglutide), commonly used for diabetes, can help improve gut function in adults with short bowel syndrome who depend on intravenous nutrition. Twenty participants will receive either the medication or a placebo for four weeks al…
Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC